Repurposing an Antiviral Drug against SARS-CoV-2 Main Protease

被引：22
|
作者：
Sarkar, Arighna [1 ]
Mandal, Kalyaneswar [1 ]
机构：
[1] Tata Inst Fundamental Res Hyderabad, TIFR Ctr Interdisciplinary Sci, 36-P Gopanpally, Hyderabad 500046, Telangana, India
来源：
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION | 2021年 / 60卷 / 44期
关键词：
allosteric inhibitors; antiviral drugs; drug screening; SARS-CoV-2; X-ray crystallographic screening;
D O I：
10.1002/anie.202107481
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
[No abstract available]
引用
收藏
页码：23492 / 23494
页数：3
相关论文
共 50 条
  • [1] Impact of Drug Repurposing on SARS-Cov-2 Main Protease
    Ndagi, Umar
    Abdullahi, Maryam
    Hamza, Asmau N. N.
    Magaji, Mohd G. G.
    Mhlongo, Ndumiso N. N.
    Babazhitsu, Makun
    Majiya, Hussaini
    Makun, Hussaini Anthony
    Lawal, Monsurat M. M.
    RUSSIAN JOURNAL OF PHYSICAL CHEMISTRY A, 2022, 96 (14) : 3311 - 3330
  • [2] Impact of Drug Repurposing on SARS-Cov-2 Main Protease
    Umar Ndagi
    Maryam Abdullahi
    Asmau N. Hamza
    Mohd G. Magaji
    Ndumiso N. Mhlongo
    Makun Babazhitsu
    Hussaini Majiya
    Hussaini Anthony Makun
    Monsurat M. Lawal
    Russian Journal of Physical Chemistry A, 2022, 96 : 3311 - 3330
  • [3] Rutin: A Potential Antiviral for Repurposing as a SARS-CoV-2 Main Protease (Mpro) Inhibitor
    Agrawal, Pawan K.
    Agrawal, Chandan
    Blunden, Gerald
    NATURAL PRODUCT COMMUNICATIONS, 2021, 16 (04)
  • [4] Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study
    Baby, Krishnaprasad
    Maity, Swastika
    Mehta, Chetan H.
    Suresh, Akhil
    Nayak, Usha Y.
    Nayak, Yogendra
    ARCHIVES OF MEDICAL RESEARCH, 2021, 52 (01) : 38 - 47
  • [5] Computational drug repurposing for the identification of SARS-CoV-2 main protease inhibitors
    Fiorucci, Diego
    Milletti, Eva
    Orofino, Francesco
    Brizzi, Antonella
    Mugnaini, Claudia
    Corelli, Federico
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (16): : 6242 - 6248
  • [6] In silico molecular docking analysis for repurposing approved antiviral drugs against SARS-CoV-2 main protease
    Khater, Ibrahim
    Nassar, Aaya
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2021, 27
  • [7] Integrated computational approach towards repurposing of antimalarial drug against SARS-CoV-2 main protease
    Neelutpal Gogoi
    Purvita Chowdhury
    Ashis Kumar Goswami
    Aparoop Das
    Dipak Chetia
    Bhaskarjyoti Gogoi
    Structural Chemistry, 2022, 33 : 1409 - 1422
  • [8] Integrated computational approach towards repurposing of antimalarial drug against SARS-CoV-2 main protease
    Gogoi, Neelutpal
    Chowdhury, Purvita
    Goswami, Ashis Kumar
    Das, Aparoop
    Chetia, Dipak
    Gogoi, Bhaskarjyoti
    STRUCTURAL CHEMISTRY, 2022, 33 (05) : 1409 - 1422
  • [9] Research Progress of Antiviral Drug Targeting the Main Protease of SARS-CoV-2
    Wang, Chunxia
    Hu, Xiaodong
    Xu, Bin
    Cao, Chunyang
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2022, 42 (07) : 1974 - 1999
  • [10] In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro SARS-CoV-2
    Baby, Krishnaprasad
    Maity, Swastika
    Mehta, Chetan
    Suresh, Akhil
    Nayak, Usha Y.
    Nayak, Yogendra
    PHARMACEUTICAL SCIENCES, 2020, 26 : S52 - S62
12345